Medicare enrollees to pay 50% less for some drugs in 2025, report says
(Removes word "embargo" from headline)
By Ahmed Aboulenein
WASHINGTON, Dec 18 (Reuters) - Americans enrolled in Medicare will pay about 50% less out of pocket in 2026 for some drugs including Pfizer and Bristol Myers Squibb's blood thinner Eliquis and Merck & Co's diabetes drug Januvia,... Read More.


